What Substack’s Community Round Means for Equity Crowdfunding

April 19, 2023

Earlier this month, we celebrated the 11-year anniversary of the JOBS Act, which opened the doors for thousands of issuers to raise capital from their communities via Reg CF and Reg A+. In the years that have passed, 1.5 million investors have poured more than $1.63 billion into Reg CF offerings alone.

Still, equity crowdfunding makes up just a small fraction of the total capital deployed into startups each year. In 2022, for example, US venture capital investments totaled more than $209 billion—but while VC deal count dropped precipitously last year, equity crowdfunding deals increased by 16%. 

That growth is expected to continue, especially as larger, more well-known startups start to join the mix. Take Substack, for example—a VC-backed newsletter platform with $86 million in funding to date and more than 35 million active subscribers. The company launched a Reg CF campaign at the end of March with the goal of raising $2 million from its community of writers and readers. Within the first day, they received so many commitments that they bumped their target amount up to the legal maximum of $5 million—and as of this writing, they’re still oversubscribed by more than 50%. 

Jonathan Stidd, President of DealMaker Reach, says Substack is the perfect case study for community-based companies seeking funding.

Smiling man (Jon Stidd - President of DealMaker Reach) with yellow brick background.
“They have an audience already that they can tap into—particularly one that they can offer a lot of value to. They can say, ‘Hey, as a writer or reader, you are a valuable member to this platform and its future, so we want to offer you equity and upside in that future.’ The people and groups that are literally building the platform get the chance to invest in it—which is just super cool.”

In the early days of equity crowdfunding, the vast majority of offerings were for pre-seed or seed-stage companies, many of which had little to no revenue. But as the space has evolved, it increasingly resembles the overall funding ecosystem, with companies from pre-seed to Series E and beyond getting a piece of the action.

That’s because, even for startups with top-tier venture backing, equity crowdfunding is a powerful way to turn customers into shareholders (and vice versa). It’s a community-building move, a strong PR play, and a capital infusion all at once—and a successful campaign like Substack’s can be spun up in just a few weeks. 

For Substack, a $5M raise isn’t intended to replace a full financing round. It’s an add-on allocation to its $65M Series B from 2021, set aside so that its community can benefit from the platform’s potential success.

It may also be functioning as a low-cost bridge round; Substack reportedly abandoned plans to raise more money last year as market conditions tightened. According to CB Insights, valuations dropped across all funding rounds except Seed/Angel from Q4 2021 to Q4 2022:


“The big seize up in capital, the pause in funding, is more heavily weighted towards the later-stage folks—Series A and beyond,” Stidd says. “So if you can raise capital quickly from your audience, at a relatively low cost of capital, that puts you in a good state to survive this downturn. There will be a lot of companies that die. So for [Substack], I think it was resourcefulness where, sure, funding is slow now. But Substack is proof that you can directly access your audience and raise really meaningful capital quickly.”

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

Monogram at NASDAQ celebration

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

  • Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
  • Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
  • A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
  • Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date End Date Type Platform Amount Raised # Investors
3/13/193/31/20A+SeedInvest$14,588,6686,000
11/16/201/16/21A+StartEngine$2,965,5018,000
1/17/212/18/22A+StartEngine$23,647,85314,082
7/15/223/16/23CFDealMaker$4,673,0002,249
3/1/234/8/23A+Republic$232,275120
3/1/235/23/23A+DealMaker$15,958,3645,198
5/18/23-Nasdaq listing
7/2410/24Unit OfferingDealMaker$12,990,1032,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+
Raised across seven campaigns
~40,000
Investors championing Monogram's vision
20%
Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

  • Filed its first patent application in 2017
  • Conducted clinical studies at UCLA and University of Nebraska
  • Expanded the team with key hires
  • Attracted a top-tier advisory board to guide clinical innovations
  • Signed their first distribution partnerships
  • Made headlines with cutting-edge live demonstrations
  • Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

  • Go from concept to commercialization without relying on VCs
  • Retain ownership and control in a high-burn industry
  • Build a base of loyal shareholders who invested not once, but over and over again
  • Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Dr. Doug Unis Quote
Ben Sexson Quote

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker
DealMaker Logo

The ultimate technology for raising capital online

Talk to the experts
The ultimate technology for raising capital online - talk to the experts